The expression or phosphorylation of ROR1 has shown good correlation with disease stages in patients with chronic lymphocytic leukemia (CLL) [38], ovarian cancer [22,24], pancreatic adenocarcinomas [22], and breast cancer [23]. This evidence concerns the gene ROR1 and breast carcinoma.